Efficacy of Ranolazine in Patients With Chronic Angina
Authors:
- Benjamin M. SciricaBSBenjamin M. Scirica
- Eugene BraunwaldEBEugene Braunwald
- Sabina A. MurphySMSabina A. Murphy
- Ewa Karwatowska-ProkopczukEKEwa Karwatowska-Prokopczuk
- Jacqueline L. BurosJBJacqueline L. Buros
- Bernard R. ChaitmanBCBernard R. Chaitman
- David A. MorrowDMDavid A. Morrow
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Optimal Medical Therapy with or without PCI for Stable Coronary DiseaseNew England Journal of Medicine, 2007
- Antianginal Efficacy of Ranolazine When Added to Treatment With AmlodipineJACC, 2006
- Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non–ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trialAmerican Heart Journal, 2006
- Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular ConditionsCirculation, 2006
- Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic PropertiesCirculation, 2004
- Impact of angina burden and other factors on treatment satisfaction after acute coronary syndromesAmerican Heart Journal, 2003
- ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary articleJACC, 2003
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001
- Characteristics of a contemporary population with angina pectorisThe American Journal of Cardiology, 1994
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992